The proposed bill would update current statutes by introducing new regulations concerning stem cell and birth tissue therapies. It would prohibit physicians from performing or participating in any therapies involving cells or tissues derived from aborted fetuses or embryos, classifying such actions as a class 5 felony. Additionally, the bill would allow physicians to conduct certain non-FDA approved therapies under strict conditions, ensuring that the cells or tissues used are sourced from accredited facilities and meet specific safety criteria. Moreover, the bill would require informed consent from patients prior to administering therapies, detailing the treatment's nature, its unapproved status by the FDA, and associated risks and benefits. It would also enable individuals harmed by non-compliant therapies to seek civil damages and grant relevant medical boards the authority to adopt necessary rules for implementation. Overall, these updates aim to enhance safety and ethical standards in stem cell and birth tissue therapies while imposing strict penalties for violations.

Statutes affected:
Introduced Version: